Convenient, affordable, and available over the counter
Adam Spitz, an endocrinologist, and Georgina Farrow, a clinical pharmacist, to unpack the science, success stories, safety concerns, and future outlook for GLP-1 medications like Ozempic and Mounjaro for people with T1D
Others may have less experience with these medications
The stomach injection is the most popular choice for a reason, but it is not the only option and it is not always the best one for every person
Nevertheless, This study provides the first evidence of a formulation-and dose-dependent ION risk, with the strongest association observed for Wegovy, write the researchers, concluding: These findings highlight a potential dose-dependent safety concern that warrants urgent prospective evaluation to guide prescribing and regulatory policy. The authors of a linked commentary agree
Ergsy carefully checks the information in the videos we provide here